Enova International announced a new $500 million share repurchase program, replacing its existing $400 million plan set to expire in June 2027. This new program, the largest in the company's history, will run until June 30, 2028, reflecting confidence in Enova's business model and growth prospects. The company plans to buy back shares through open market purchases or private transactions, maintaining financial flexibility to support long-term shareholder value. The program may be adjusted or terminated at the Board's discretion.
Enova International's new $500 million share repurchase program is the largest in its history, set to run until June 30, 2028. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 10, 2026 18:42 WIB: out of 142 priced US Financials stocks, 90 rose and 45 fell today. Notable movers include Mizuho Financial Group Inc. ADR (MFG) at USD 10.21 with a 4.02% gain and a typical hold time of 8 days, Deutsche Bank AG (DB) at USD 37.57 with a 2.73% gain and a typical hold time of 82 days, and Blue Owl Capital Inc. Class A (OWL) at USD 10.11 down 2.51%.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
